Myopia progression after cessation of low‐dose atropine eyedrops ...

Myopia progression after cessation of low-dose atropine eyedrops ...

The difference in myopia progression between atropine-placebo group and placebo-atropine group in Phase 1 was similar to Phase 2 during the ...

Although the 2-year progression of myopia was similar in two groups, it does not exclude the possibility of rebound effect. The natural ...

Myopia progression after cessation of atropine in children - Frontiers

In a single study in which patients transitioned from 1% QW to 0.01% QD, (Ye et al., 2022), the rate of myopia progression was −1.64 ± 0.90 D/y ...

Myopia Progression After Cessation of Low-Dose Atropine Treatment

This cross-over trial suggests no rebound effect after using 0.01% atropine eye drops to prevent myopia progression. Abstract. Myopia ...

Myopia progression after cessation of atropine in children - NCBI

Conclusion: Our meta-analysis highlights the temporal and dose-dependent rebound effects after discontinuing atropine. Individuals with shorter ...

Myopia progression after cessation of low‐dose atropine eyedrops ...

In the first year, the mean myopia progression in atropine-placebo group was 0.21 ± 0.08 D slower than that in placebo-atropine group. After ...

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

004) with atropine, 0.01%, after 1 year of treatment compared with placebo and a reduction in axial length elongation (0.36 mm vs 0.41 mm; P = .

A DROP A DAY TO KEEP MYOPIA AT BAY - Contact Lens Spectrum

ATROPINE EYE DROPS are employed by eyecare practitioners to curb myopic progression and the development of pathological myopia.

Low-Concentration Atropine Eye Drops for Myopia Progression

In addition to the side effects, high concentration atropine leads to a significant rebound following cessation of eye drops.38 In ATOM1, myopic progression ...

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2

Over 5 years, atropine 0.01% eyedrops were more effective in slowing myopia progression with less visual side effects compared with higher doses of atropine.

Safety and Efficacy of Low-Dose Atropine Eyedrops for the ...

In 2006, the Atropine for the Treatment of Myopia 1 (ATOM 1) study found that the mean (SD) rate of myopia progression after 2 years was only − ...

Low-dose atropine drops, 0.01%, ineffective in stopping myopia ...

A recent study found that the use of low-dose atropine drops is ineffective in slowing pediatric myopia progression, contradicting a ...

Low-dose AtropIne for Myopia Control in Children (AIM) - BMJ Open

Introduction Myopia is a major cause of degenerative eye disease and increases the risk of secondary visual impairment. Mitigating its progression therefore ...

Update in myopia and treatment strategy of atropine use in ... - Nature

Atropine is currently the most effective therapy for myopia control. Recent clinical trials demonstrated low-dose atropine eye drops such as 0.01% resulted in ...

Low-Dose Atropine for Kids with Myopia

Studies show that a low-dose of atropine, typically given as eye drops at bedtime, can significantly slow the progression of myopia in children, preventing ...

Effect of low-dose atropine eyedrops on pupil metrics: results after ...

Pupil metrics and the CR could return to pre-atropine levels after cessation. Pupil metrics had no significant effect on myopia progression ...

Myopia progression after cessation of low‐dose atropine eyedrops ...

Conclusions: For myopic children, atropine 0.01% eyedrops can alleviate relative hyperopia in the temporal retina and the hyperopic shift before cycloplegia.

Three-Year Clinical Trial of Low-Concentration Atropine for Myopia ...

In the Phase One and Phase Two results of the Low-concentration Atropine for Myopia Progression (LAMP) study, 0.05% atropine was shown to be the ...

Topical Atropine in the Control of Myopia - ScienceDirect.com

Topical atropine reduces myopia progression and axial elongation in children in a dose-related manner, but a rebound phenomenon occurs with higher doses.

Study Finds Low-dose Atropine Ineffective vs. Myopia

Another study saw myopia progression reduction after two years and another after one year, while yet another saw reduction in mean SER ...